Russian covid-19 vaccine Sputnik Lite is about to enter the Iranian market, Coronavirus Control Headquarters in Tehran Alireza Zali said.

"Satellite Lite will soon enter the Iranian vaccine market. "The single-component Sputnik Lite vaccine has fewer side effects than other drugs," Zali said in an interview with ISNAnews agency, as quoted by TASS.

The Sputnik Lite vaccine is the first component (recombinant human adenovirus serotype 26 (rAd26)) of the Sputnik V vaccine. The efficacy of the single component Sputnik Lite vaccine is 79.4% from day 28 after receiving immunization. Now the vaccine is not only used alone, but is being studied in combination with products from other manufacturers.

Made in Russia // Made in Russia

Author: Karina Kamalova